Stuart M Lichtman Selected Research

Stuart M Lichtman Research Topics

Disease

44	Neoplasms (Cancer) 04/2024 - 01/2002
13	Ovarian Neoplasms (Ovarian Cancer) 04/2024 - 08/2007
7	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 04/2005
6	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2008
3	Ovarian Epithelial Carcinoma 01/2023 - 08/2007
3	Anemia 10/2015 - 11/2003
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2005 - 01/2002
2	Lung Neoplasms (Lung Cancer) 11/2016 - 04/2011
2	Drug-Related Side Effects and Adverse Reactions 08/2014 - 05/2014
2	Leukemia 04/2006 - 12/2004
2	Colonic Neoplasms (Colon Cancer) 09/2005 - 01/2005
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2023
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Cardiotoxicity 10/2021
1	COVID-19 01/2021
1	Infections 11/2020
1	Cognitive Dysfunction 01/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Vision Disorders (Hemeralopia) 01/2018
1	Body Weight (Weight, Body) 01/2017
1	Frailty 12/2016
1	Chemotherapy-Related Cognitive Impairment 01/2016
1	Liver Neoplasms (Liver Cancer) 12/2015
1	Heart Diseases (Heart Disease) 01/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2013
1	Hypertension (High Blood Pressure) 01/2013
1	Hypersensitivity (Allergy) 03/2010
1	Neutropenia 04/2006
1	Stomatitis 04/2005
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2005
1	Pseudomyxoma Peritonei 04/2004
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2002
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2002

Drug/Important Bio-Agent (IBA)

5	PlatinumIBA 01/2023 - 08/2007
4	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 03/2010
4	Capecitabine (Xeloda)FDA Link 03/2016 - 04/2004
3	Biomarkers (Surrogate Marker)IBA 04/2024 - 07/2013
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 12/2004
2	CreatinineIBA 01/2023 - 01/2017
2	Fluorouracil (Carac)FDA LinkGeneric 03/2016 - 04/2005
2	Bevacizumab (Avastin)FDA Link 01/2013 - 04/2005
1	NivolumabIBA 04/2024
1	human ERBB2 proteinIBA 01/2022
1	Androgen Receptor AntagonistsIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	thiamine triphosphorate (TTP)IBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Serum AlbuminIBA 01/2022
1	enzalutamideIBA 01/2022
1	AlbuminsIBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019
1	olaparibIBA 01/2019
1	niraparibIBA 01/2019
1	rucaparibIBA 01/2019
1	Methotrexate (Mexate)FDA LinkGeneric 03/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2016
1	Monoclonal AntibodiesIBA 03/2016
1	Biosimilar PharmaceuticalsIBA 03/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2016
1	Hemoglobins (Hemoglobin)IBA 10/2015
1	Opioid Analgesics (Opioids)IBA 08/2014
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2014
1	AnticoagulantsIBA 08/2014
1	Insulin (Novolin)FDA Link 08/2014
1	Hypoglycemic Agents (Hypoglycemics)IBA 08/2014
1	VitaminsIBA 10/2012
1	Cisplatin (Platino)FDA LinkGeneric 03/2010
1	taxaneIBA 08/2007
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2007
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2006
1	Antineoplastic Agents (Antineoplastics)IBA 05/2003
1	fludarabineIBA 01/2002
1	fludarabine phosphate (Fludara)FDA LinkGeneric 01/2002

Therapy/Procedure

39	Drug Therapy (Chemotherapy) 01/2023 - 01/2002
20	Therapeutics 04/2024 - 01/2005
5	Polypharmacy 01/2022 - 11/2003
3	Radiotherapy 01/2023 - 01/2008
3	Activities of Daily Living (ADL) 01/2018 - 10/2012
2	Palliative Care (Palliative Therapy) 11/2020 - 04/2011
2	Drug Tapering 03/2015 - 07/2013
1	Preoperative Exercise 01/2023
1	Combined Modality Therapy 01/2022
1	Hyperthermic Intraperitoneal Chemotherapy 10/2021
1	Cytoreduction Surgical Procedures 10/2021
1	Aftercare (After-Treatment) 04/2021
1	Continuity of Patient Care 11/2020
1	Biological Therapy 03/2016
1	Precision Medicine 08/2014
1	Premedication 03/2010
1	Retreatment 03/2010